openPR Logo
Press release

Multiple Sclerosis Market - Opportunity Analysis & Industry Forecast, 2017-2023

09-24-2018 02:25 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Analytics
Multiple Sclerosis Market

Multiple Sclerosis Market

Multiple sclerosis (MS) is an inflammatory disease of nervous system, which is also referred as disseminated sclerosis. Multiple sclerosis is progressed with disruption spinal cord and brain nerve cells, which results in loss of ability of the parts of the nervous system to communicate including various other mental, physical and psychiatric problems. Primary progressive multiple sclerosis (PPMS) is the type of multiple sclerosis in which neurological functions are steadily deteriorated with minimal distinct relapses (exacerbations and attacks) or the fixed period remissions. The progression rates of PPMS may vary from person to person and over the timeframes, which may show the signs of transitory improvements, however, the progression of disease remains persistent. Currently, PPMS market is facing lucrative growth owing to the rising incidences of multiple sclerosis worldwide. Increasing patients’ base may promote the future growth of this market.

Access Full Summary: http://bit.ly/2xCBMDy

Presently, various types of relapsing multiple sclerosis are gradually affecting the large number of populations worldwide, e.g., secondary-progressive multiple sclerosis, relapsing remitting multiple sclerosis, primary progressive multiple sclerosis, and progressive relapsing multiple sclerosis. According to multiple sclerosis web portal (by Health Union, United States), more than 2.5 million people are affected by multiple sclerosis globally. Among all types of multiple sclerosis, 10‐15% patients suffer from PPMS. It is difficult to treat as well as diagnose these patients. Hence, elevated demand for the advanced therapeutic treatment will fuel the growth of PPMS market.

Request Sample Report: http://bit.ly/2QRDzN8

Geographically, North America and Europe would be the lucrative segment for the growth of this market owing to the high prevalence rates of multiple sclerosis and rising demands for therapeutic medications for the effective treatment of PPMS in these regions. According to multiple sclerosis portal, ~500,000 people are affected with multiple sclerosis in Europe and ~400,000 affected population is present in the United States.

KEY BENEFITS

The analysis made in this report helps in understanding the strategies adopted by various companies for gaining market share in PPMS market
The report provides the quantitative analysis of the current market and estimations through 2014-2021 that assists in identifying the prevailing market opportunities to capitalize on
This report provides a comprehensive analysis of factors that drive and restrict the growth of the PPMS market
Detailed study of the strategies of key leaders, partnerships and acquisitions in the global PPMS market would be informative for professionals in the corporate sector
Porter’s Five Forces analysis examines the competitive structure of the global PPMS market and would assist market strategists in making decisions
Pin-point analysis of geographic segments helps to identify opportunities for growth within the PPMS market
Identification of key investment pockets for PPMS market provide strategic assistance to decision makers
An analysis for the market potential/attractiveness has been included in this report covering various product segments, therapeutics, devices and geographic regions along with a detailed analysis of factors responsible for the rapid growth of the market segments
KEY MARKET SEGMENTS

The market is segmented based on the types of treatment, location of testing, and by the geography.

PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS MARKET BY TYPE OF DIAGNOSTIC TESTS

Magnetic Resonance Imaging (MRI) Scans
Simple electrical stimulation tests
Lumbar puncture
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS MARKET BY LOCATION OF TREATMENT

Hospital testing
Commercial/private hospitals
Public health hospitals
Symptomatic diagnostic testing with medications
Clinics
Home Treatment
Managing symptoms
Rehabilitation
Healthy living
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS MARKET BY GEOGRAPHY

North America
Europe
Asia-Pacific
LAMEA

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiple Sclerosis Market - Opportunity Analysis & Industry Forecast, 2017-2023 here

News-ID: 1258521 • Views:

More Releases from Allied Market Research

Tomato Puree Market Value Projected to Expand | $7.7 Billion by 2032 With CAGR of 4.1%
Tomato Puree Market Value Projected to Expand | $7.7 Billion by 2032 With CAGR o …
The tomato puree market was valued at $5.2 billion in 2022, and is estimated to reach $7.7 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032. Tomato puree is a thick liquid or paste made by cooking and straining tomatoes to remove seeds and skins. It is a concentrated form of tomatoes that retains the rich flavor and vibrant color of the tomatoes. In the process
Olive Oil Market to Witness Robust Expansion | $30.2 Billion by 2032
Olive Oil Market to Witness Robust Expansion | $30.2 Billion by 2032
The olive oil market size was valued at $18.6 billion in 2022, and is estimated to reach $30.2 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032. The Olive Oil Industry is driven by a rise in the number of cooking shows and food blogging. Celebrity chefs and influencers often showcase olive oil as a star ingredient in various culinary creations, emphasizing its versatility and health benefits.
Digital Map Market Growth, Size, Future Scope and Industry Forecast 2032
Digital Map Market Growth, Size, Future Scope and Industry Forecast 2032
The digital map industry was valued at $21.8 billion in 2022, and is estimated to reach $89.1 billion by 2032, growing at a CAGR of 15.4% from 2023 to 2032. The service segment is expected to experience fastest growth in the coming years. The adoption of digital mapping service enhances software implementation, maximizes the value of existing installation by optimizing it, and minimizes the deployment cost & risks, and others, which
Dialysis Concentrate Market Top Companies, Business Growth
Dialysis Concentrate Market Top Companies, Business Growth
The global dialysis concentrate market was valued at $2.69 billion in 2020 and is projected to reach $4.53 billion by 2030, registering a CAGR of 5.40% from 2021 to 2030. Dialysis concentrate is any fluid used in the application of dialysis that comprises of glucose, electrolyte, and purified water. The electrolyte solution is prepared in such a way that it matches the concentration present naturally in the blood. The dialysis solution

All 5 Releases


More Releases for PPMS

Primary Progressive Multiple Sclerosis Market Size, Share, Epidemiology, Drugs, …
DelveInsight's "Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To know more about Primary Progressive Multiple Sclerosis, Click here: https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr Some facts of the Primary Progressive Multiple
PPMS and SPMS: Epidemiology and Market Forecasts to 2030
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS. SPMS: Epidemiology and Market Forecasts to 2030 SPMS is characterized by a continuous increase in disability and worsening of symptoms with or without the period of relapses
Primary Progressive Multiple Sclerosis Market to Witness Exponential Growth by 2 …
Multiple sclerosis (MS), which is also referred as disseminated sclerosis, is an inflammatory disease of the nervous system. It is mainly characterized by the disruption of the nerve cells of the spinal cord and the brain of an affected individual, which results in the loss of ability to communicate along with various other physical, mental as well as psychiatric problems. Primary progressive multiple sclerosis (PPMS) is a type of MS
Primary Progressive MS – Strong pipeline in progressive MS indicates a paradig …
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS. Primary progressive multiple sclerosis is primarily characterized by progression of disease activity and the disability amongst the patients. As per the latest report by Pharmascroll, PPMS-
Primary Progressive Multiple Sclerosis Market Pegged For Robust Expansion During …
Multiple sclerosis (MS), which is also referred as disseminated sclerosis, is an inflammatory disease of the nervous system. It is mainly characterized by the disruption of the nerve cells of the spinal cord and the brain of an affected individual, which results in the loss of ability to communicate along with various other physical, mental as well as psychiatric problems. Primary Progressive Multiple Sclerosis (PPMS) is a type of MS
Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Emerging Therap …
Market Research HUBs Primary Progressive Multiple Sclerosis (PPMS) -Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Primary Progressive Multiple Sclerosis (PPMS) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Primary